Evidence map›Paper›PMID 31583002›Full record

ArticleIranian journal of pathology2019

Inter-observer Variability in Histomorphological Evaluation of Non-neoplastic Liver Biopsy Tissue and Impact of Clinical Information on Final Diagnosis in Shahid Beheshti University of Medical Sciences Affiliated Hospitals.

Zeinab Kishanifarahani, Mahsa Ahadi, Behrang Kazeminejad, Tahmineh Mollasharifi, Malihe Saber Afsharian, Amir Sadeghi, Farahnaz Bidari, Elena Jamali, Niki Hasanzadeh, Abolfazl Movafagh and 3 more

Abstract read
In one paragraph

Article in Iranian journal of pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Zeinab KishanifarahaniCancer Research Center, Shohada-e-Tajrish Educational Hospital, Faculty of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran.
Mahsa AhadiCancer Research Center, Shohada-e-Tajrish Educational Hospital, Faculty of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran.
Behrang KazeminejadCancer Research Center, Shohada-e-Tajrish Educational Hospital, Faculty of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran.
Tahmineh MollasharifiCancer Research Center, Shohada-e-Tajrish Educational Hospital, Faculty of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran.
Malihe Saber AfsharianPathology Department, Azad Medical University, Mashhad, Iran.
Amir SadeghiResearch Center for Gastroenterology and Liver Diseases, Taleghani Educational Hospital, Faculty of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran.
Farahnaz BidariCancer Research Center, Shohada-e-Tajrish Educational Hospital, Faculty of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran.
Elena JamaliCancer Research Center, Shohada-e-Tajrish Educational Hospital, Faculty of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran.
Niki HasanzadehCancer Research Center, Shohada-e-Tajrish Educational Hospital, Faculty of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran.
Abolfazl MovafaghCancer Research Center, Shohada-e-Tajrish Educational Hospital, Faculty of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran.
Arash DehghanPathology Department, Hamadan University of Medical Sciences, Hamadan, Iran.
Arsham MoradiUniversity of Toronto, Department of Biology, Toronto, Canada.
Afshin MoradiCancer Research Center, Shohada-e-Tajrish Educational Hospital, Faculty of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND &

objectiveLiver biopsy is the main method for grading and staging liver disorders, but the effects of clinical information and optimal biopsy specimen size on interpretation remain contentious. The aim of the study was to evaluate the impact of clinical information and quality of liver specimen on inter-observer agreement for liver disease.

methodsA total of 289 consecutive biopsy specimens from 2010 to 2017 were re-evaluated by five pathologists using the modified Ishak and non-alcoholic fatty liver diseases (NAFLD) activity score (NAS) systems. Detailed clinical information was extracted from medical records of patients and the size of all liver biopsy samples was recorded.

resultsFull agreement between primary diagnosis and final diagnosis was obtained in 214 cases (74%). The remaining cases, namely 22 (7.6%) and 53 (18.3%) biopsies had minor and major diagnostic discrepancies, respectively. The results showed that the overall agreement was significantly higher in cases with complete clinical information than patients without any clinical information and even with partial clinical information (

conclusionThis study identified the impact of clinical information and the number of portal tracts as the key factors to diagnosis. Therefore, request forms for liver biopsies should always be accompanied with the clinical history. Moreover, adequacy of biopsy specimens is very useful for accurate evaluation of samples by pathologists.

Indexed as

GradingInter-observerLiver biopsyPathologyStaging

Identifiers

PMID31583002
PMCPMC6742738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.